Frailty

The supplied grounding does not support a specific cause or single aetiology for frailty. The literature instead emphasizes associations with aging and, in some studies, the gastrointestinal microbiome. Review material also notes overlap with comorbidity and cardiovascular disease, but not a definitive causal pathway.

Frailty is described as reflecting declines in function and reserve across multiple physiologic systems, producing reduced resilience to stressors. The grounding also links frailty research to aging and the gastrointestinal microbiome, suggesting involvement of age-related biological change and host-microbiome relationships. Beyond this, the supplied material does not support a more specific mechanism.

Older age is the clearest risk context supported by the grounding, since the guidelines and reviews focus on older adults. The literature also associates frailty with comorbidity and cardiovascular disease, and with low physical activity and other unhealthy lifestyles in the context of reduced activity. The supplied material additionally suggests possible links with the gastrointestinal microbiome, but does not establish this as a risk factor.

The guidelines support case identification or screening of older adults for frailty using a validated instrument. Management is described at a general level as person-centred care for older people with frailty, with recommendations based on the available evidence and consensus where evidence is limited. The grounding does not support specific drug classes or modality-based treatments beyond identification, assessment, and general management approaches.